Long-term effects of non-surgical therapy for obesity on cardiovascular risk management: A weighted empirical review

被引:4
作者
Laederach-Hofmann K. [1 ,5 ]
Messerli-Burgy N. [2 ,3 ]
Meyer K. [4 ]
机构
[1] Division of Endocrinology, Diabetology, and Clinical Nutrition, Inselspital, University of Berne, Berne
[2] Psychobiology Group, Department of Epidemiology and Public Health, University College London, London
[3] Institute of Psychology, Clinical Psychology and Psychotherapy Unit, University of Berne, Berne
[4] Swiss Health Observatory, University of Berne, Berne
[5] ZAEP, University of Berne, Inselspital
关键词
Cardiovascular risk profile; Non-surgical therapy; RCTs; Weight loss;
D O I
10.1007/s10389-007-0161-x
中图分类号
学科分类号
摘要
Weight loss affects cardiovascular risk profiles in obese patients. Surgery is not a plausible or viable response to the public health problem of obesity, given that more than 30% of adults are obese in some countries. However, most studies investigating the effects of weight loss on the cardiovascular risk profile are focussed on weight loss and limited to short-term effects. Since newer data show a rebound of cardiovascular risks in studies that complete a short-term follow-up, the question arises whether, and to what extent, long-term treatments offer a more sustained cardiovascular benefit beside the extensive or less marked weight loss. Aims: The purpose of this article is to critically review existing data on the long-term cardiovascular effects of weight loss in obese and overweight patients treated with dietary interventions, physical activity programmes, behavioural therapy and pharmacological treatments and their combination. Method: Inclusion criteria were peer-reviewed, randomized controlled trials (RCT) in the English language which presented data on cardiovascular effects at a follow-up of at least 18 months during or after weight reduction interventions. The search was limited to adults and the publication years between 1990 and 2007. Studies of patients with diagnoses such as coronary heart disease and cancer, and medically treated diabetes and hypertension were excluded. Results: Twenty-three studies measured cardiovascular risk factors after 18 months or more. Mean BMI was 33.9 kg/m2 including 13,733 patients. Mean duration of the studies was 37 months with a dropout rate of 16.1% on average. Regardless of the absolute amount of weight loss a positive effect on cardiovascular risk factors such as blood pressure, lipids and glucose tolerance was found. © 2007 Springer-Verlag.
引用
收藏
页码:21 / 29
页数:8
相关论文
共 48 条
[1]  
Aronne L.J., Thornton-Jones Z.D., New targets for obesity pharmacotherapy, Clin Pharmacol Ther, 81, pp. 748-752, (2007)
[2]  
Berenson G.S., Srinivasan S.R., Emergence of obesity and cardiovascular risk for coronary artery disease: The Bogalusa Heart Study, Prev Cardiol, 4, pp. 116-121, (2001)
[3]  
Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance, JAMA, 290, pp. 486-494, (2003)
[4]  
Curioni C., Andre C., Rimonabant for overweight or obesity, Cochrane Database Syst Rev, 4, (2006)
[5]  
Davidson M.H., Hauptman J., Digirolamo M., Foreyt J.P., Halsted C.H., Heber D., Heimburger D.C., Lucas C.P., Robbins D.C., Chung J., Heymsfield S.B., Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: A randomized controlled trial, JAMA, 281, pp. 235-242, (1999)
[6]  
Deedwania P.C., Gupta R., Management issues in the metabolic syndrome, J Assoc Physicians India, 54, pp. 797-810, (2006)
[7]  
Despres J.P., Golay A., Sjostrom L., Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia, N Engl J Med, 353, pp. 2121-2134, (2005)
[8]  
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, pp. 393-403, (2002)
[9]  
Ditschuneit H.H., Fletchner-Mors M., Johnson T.D., Adler G., Metabolic and weight-loss effects of a long-term dietary intervention in obese patients, Am J Clin Nutr, 69, pp. 198-204, (1999)
[10]  
Douketis J.D., MacIe C., Thabane L., Williamson D.F., Systematic review of long-term weight loss studies in obese adults: Clinical significance and applicability to clinical practice, Int J Obes (Lond), 29, pp. 1153-1167, (2005)